INT314780

Context Info Confidence 0.13 First Reported 2010 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 1.53 Pain Relevance 1.17

extracellular region (Postn) cell adhesion (Postn) proteinaceous extracellular matrix (Postn) extracellular matrix organization (Postn)

Postn (Mus musculus)

Pain Link Frequency Relevance Heat Analgesic 6 99.48 Neuropathic pain 11 97.92 Pain score 3 89.60 Pain 51 88.48 Pain scale 1 85.60 peripheral neuropathy 6 59.76 Mcgill questionnaire 4 8.08 diabetic neuropathy 5 5.00 Duloxetine 3 5.00 pregabalin 3 5.00

Disease Link Frequency Relevance Heat Neuropathic Pain 12 97.92 Diabetes Mellitus 14 94.96 Pain 62 89.32 Peripheral Neuropathy 12 59.76 Dizziness 2 5.00 Xerostomia 2 5.00 Poisoning 1 5.00 Sleep Disorders 1 5.00 Injury 1 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

A randomized, double blind placebo controlled clinical trial was conducted to assess the efficacy of the Neuragen PN®, a topical analgesic formula, in the treatment of neuropathic pain.

Regulation (efficacy) of Neuragen PN associated with analgesic and neuropathic pain

1) Confidence 0.13 Published 2010 Journal BMC Complement Altern Med Section Body Doc Link PMC2883533 Disease Relevance 1.53 Pain Relevance 1.17

General Comments

This test has worked.